Tianjin Zhong Xin Pharmaceutical is a play on the growing incidence of cardiovascular diseases in China. The delisting of Tianjin Zhong Xin Pharmaceutical is a potential catalyst that could unlock the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback